Heterogeneity of amiodarone-induced thyrotoxicosis: Evaluation of colour-flow Doppler sonography in predicting therapeutic response

Internal Medicine Journal

Volumn 33, Issue 9-10, 2003, Pages 420-426

  Wong, R ^a   Cheung, W ^a   Stockigt, J R ^a,b   Topliss, D J ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Amiodarone; Iodine; Thyroid; Thyrotoxicosis; Ultrasound

Indexed keywords

AMIODARONE; PREDNISOLONE; THIONAMIDE;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATIC HEART DISEASE; TEACHING HOSPITAL; THYROID FUNCTION; THYROID WEIGHT; THYROIDECTOMY; THYROTOXICOSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PREDNISOLONE; THYROIDECTOMY; THYROTOXICOSIS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0142106007     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2003.00463.x     Document Type: Article

References (25)

1. Campbell TJ. The place of amiodarone: an overview of the four recent large controlled trials. Aust NZ J Med 1997; 27: 582-90.
2. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M et al. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 2000; 342: 913-20.
3. Topliss DJ, Isaacs D, Lander C, McNeil J, Shenfield G, Strasser S et al. Amiodarone and pulmonary toxicity. Australian Adverse Drug Reactions Bulletin 2002; 21: 2.
4. Rao RH, McCready VR, Spathis GS. Iodine kinetic studies during amiodarone treatment. J Clin Endocrinol Metab 1986; 62: 563-8.
5. Wiersinga WM. Amiodarone and the thyroid. In: Weetman AP, Grossman A, eds. Pharmacotherapeutics of the Thyroid Gland. Heidelberg: Springer-Verlag; 1997; 225-44.
6. Bartelena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 1994; 78: 423-7.
7. Bartelena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab 1996; 81: 2930-3.
8. Newnham HH, Topliss DJ, Le Grand BA, Chosich N, Harper RW, Stockigt JR. Amiodarone-induced hyperthyroidism, assessment of the predictive value of biochemical testing and response to combined therapy using propylthiouracil and potassium perchlorate. Aust NZ J Med 1988; 18: 37-44.
9. Iudica-Souza C, Burch HB. Amiodarone-induced thyroid dysfunction. The Endocrinologist 1999; 9: 216-27.
10. Bogazzi F, Bartelena L, Brogioni S, Mazzeo S, Vitti P, Burelli A et al. Colour flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 1997; 7: 541-5.
11. Daniels GH. Amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 2001; 86: 3-8.
12. Martino E, Bartelena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocrine Rev 2001; 22: 240-54.
13. Ralls PW, Mayekawa DS, Lee KP, Colletti PM, Radin DR, Boswell WD et al Color-flow Doppler sonography in Graves' disease: 'thyroid inferno'. Am J Radiol 1988; 150: 781-6.
14. Solbiati L, Charboneau JW, James EM, Hay ID. The thyroid gland. In: Rumack MC, Wilson RS, Charboneau WJ, eds. Diagnostic Ultrasound. St Louis:Mosby Year Book Inc; 1998; 703-29.
15. Smyrk TC, Goellner JR, Brennan MD, Carney JA. Pathology of the thyroid in amiodarone-associated thyrotoxicosis. Am J Surg Path 1987; 11: 197-204.
16. Osman F, Franklyn J, Sheppard M, Gammage M. Successful treatment of amiodarone-induced thyrotoxicosis. Circulation 2002; 105: 1275-7.
17. Hetzel BS. Iodine deficiency disorders. In: Garrow JS, James WPT, eds. Human Nutrition and Dietetics. Edinburgh: Churchill Livingstone; 1993; 534-55.
18. Martino E, Macchia E, Aghini-Lombardi F, Antonelli A, Lenziardi R, Concetti R et al. Is humoral thyroid autoimmunity relevant in amiodarone iodine-induced thyrotoxicosis (AIIT)? Clin Endocrinol 1986; 24: 627-33.
19. Tavackoli S, Stouffer GA, Sheahan RG. Amiodarone-induced thyrotoxicosis. Am J Med Sci 1997; 314: 97-100.
20. Eaton SEM, Euinton HA, Newman CM, Weetman AP, Bennet WM. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol 2002; 56: 33-8.
21. Mercado M, Mendoza-Zubieta V, Bautista-Osorio R, Espinoza-de Los Monteras AL. Treatment of hyperthyroidism with a combination of methimazole and cholestyramine. J Clin Endocrin Metab 1996; 81: 3191-6.
22. Claxton S, Sinha SN, Donovan S, Greenaway TM, Hoffman L, Loughhead M et al. Refractory amiodarone-associated thyrotoxicosis: an indication for thyroidectomy. Aust NZ J Surg 2000; 70: 174-8.
23. Hamoir E, Meurisse M, Defechereux T, Joris J, Vivario J, Hennen G. Surgical management of amiodarone-associated thyrotoxicosis: too risky or too effective. World J Surg 1998; 22: 537-43.
24. Gough IR, Gough J. Surgical management of amiodarone-associated thyrotoxicosis. Med J Aust 2002; 176: 128-9.
25. Bogazzi F, Bartalena L, Cosci C, Brogioni S, DelliUnto E, Grasso L et al. Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. J Clin Endocrinol Metab 2003; 88: 1999-2002.